• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Magnetic Dressing Improves Diabetic Wound Healing

      Magnetic Dressing Improves Diabetic Wound Healing

      Eko’s Newest CORE 500 Stethoscope: A Review

      Eko’s Newest CORE 500 Stethoscope: A Review

      Microfluidic System Incorporates Eight Organ Tissues for Drug Testing

      Microfluidic System Incorporates Eight Organ Tissues for Drug Testing

      Suction Cup Delivers Drugs Through Cheek

      Suction Cup Delivers Drugs Through Cheek

    • Radiology
      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

    • Cardiology
      Eko’s Newest CORE 500 Stethoscope: A Review

      Eko’s Newest CORE 500 Stethoscope: A Review

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

    • Surgery
      Magnetic Dressing Improves Diabetic Wound Healing

      Magnetic Dressing Improves Diabetic Wound Healing

      Sensor Monitors Transplanted Organs for Signs of Rejection

      Sensor Monitors Transplanted Organs for Signs of Rejection

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Stretchable E-Skin for Robotic Prostheses

      Stretchable E-Skin for Robotic Prostheses

      Glasses Provide Audible Prompts for Blind Wearers

      Glasses Provide Audible Prompts for Blind Wearers

      A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

      A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

      Robotic Ankle Helps with Postural Control in Amputees

      Robotic Ankle Helps with Postural Control in Amputees

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

“Rest of the World Factor VIII Deficiency Treatment Market” to Touch US$ 3.06 Billion during 2021 to 2027 | Coherent Market Insights

May 25th, 2021 Coherent Market Insights Releases

SEATTLE, May 25, 2021, (MEDGADGET) — Rest of the World Factor VIII Deficiency Treatment Market Analysis

Drivers

Over the forecast period, new product releases by major companies in the factor VIII deficiency treatment are expected to fuel growth of the rest of the world factor viii deficiency treatment market during the forecast period. The European Commission granted Novo Nordisk marketing authorization for Esperoct in Europe in June 2019. Turoctocog alfa pegol, N8-GP, is a brand name for turoctocog alfa pegol, a drug used to treat hemophilia A in children and adults. Furthermore, Roche Products India Pvt. Ltd. unveiled emicizumab, a hemophilia A drug marketed in India as Hemlibra, in April 2019. Via Factor VIII inhibitors, it is suggested as a prophylactic therapy for reducing the incidence of bleeding episodes in patients with hemophilia A.

Request A Sample Copy – Rest of the World Factor VIII Deficiency Treatment Market Report Click here: https://www.coherentmarketinsights.com/insight/request-pdf/3257

Moreover, rising government efforts to raise public concern over hemophilia care are projected to drive growth of the rest of the world factor viii deficiency treatment market over the forecast period. To promote the successful control of hemophilia in Australia, the NBA (National Bleeding Authority) offers grants to AHCDO (Australian Hemophilia Center Directors’ Organization) for care and management of hemophilia A.

Over the forecast period, the rest of the world factor VIII deficiency treatment market is estimated to grow at a CAGR of 4.7 percent (2019-2027).

The rest of the world factor VIII deficiency treatment market is expected to rise due to an increase in the number of cases of bleeding disorders.

Due to an increase in cases of hemophilia or bleeding disorders, the rest of the world factor VIII deficiency treatment market is forecast to expand significantly. As per the Australian Bleeding Disorders Registry 2016 numbers, there were approximately 4,941 patients diagnosed with common inherited bleeding disorders in Australia in 2015, with 2,301 patients diagnosed with hemophilia A and 548 patients diagnosed with hemophilia B. Over the forecast period, the rising prevalence of hemophilia in Australia is projected to boost demand for factor VIII deficiency therapy. Furthermore, over the forecast period, rising demand for effective therapeutics for the treatment of factor VIII deficiency from developing economies such as India is expected to fuel market growth. As per 2017 figures from the World Federation of Hemophilia, about 18,353 people in India were diagnosed with hemophilia in 2016.

The market is expected to expand due to rising healthcare spending and reimbursement policies in various countries or regions.

Due to the per capita healthcare spending in Latin America, which is expected to fuel demand growth in the region over the forecast period, Latin America is expected to maintain a leading position in the rest of the world factor VIII deficiency treatment market. As per World Bank figures, healthcare spending per capita rose dramatically across Latin America over a six-year period (2008-2014), with increases of 31% in Brazil, 54% in Chile, and 58 percent in Columbia.

Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/3257

Furthermore, due to increasing favorable reimbursement policies for hemophilia care in economies such as China, Asia Pacific is projected to be the second largest dominant area in the rest of the world factor VIII deficiency treatment market. As per a 2012 survey by the Chinese Ministry of Health, outpatient hemophilia care is provided by health insurance policies in more than 80% of Chinese towns, with coverage caps and patient co-pay thresholds above 50%. Furthermore, annual reimbursement is normally less than US$ 16,000 a year.

Key Players

Key companies contributing in the rest of the world factor VIII deficiency treatment market are CSL Behring, Bayer AG, Biogen, Inc., Kedrion, Baxter International, Inc., Novo Nordisk A/S, Pfizer, Inc., F. Hoffmann-La Roche AG, and Ferring B.V.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/rest-of-the-world-factor-viii-deficiency-treatment-market-2626

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • New Therapy Developments
    • Epidemiology
    • Regulatory Scenario
    • Regulatory Guidelines
    • Reimbursement Scenario
    • PEST Analysis
    • Product Launch
    • PEST Analysis
  4. Rest of the World Factor VIII Deficiency Treatment Market, By Product Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Plasma Derived Coagulation Factor Concentrates
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million and Thousand Units)
    • Recombinant Coagulation Factor Concentrates
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million and Thousand Units)
    • Biologic (Hemlibra)
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million and Thousand Units)
    • Desmopressin
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Million and Thousand Units)
  5. Rest of the World Factor VIII Deficiency Treatment Market, By Distribution Channel, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Rest of the World Factor VIII Deficiency Treatment Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, ((US$ Million) and Volume (Thousand Units)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size (US$ Million), Volume (Thousand Units) and Forecast, and Y-o-Y Growth, By Country, 2016–2027)
        • Brazil
        • Mexico
        • Argentina
        • Colombia
        • Rest of Latin America
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million) and Volume (Thousand Units)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size (US$ Million), Volume (Thousand Units) and Forecast, and Y-o-Y Growth, By Country, 2016–2027)
        • China
        • India
        • Japan
        • ASEAN
          • Indonesia
          • Malaysia
          • Philippines
          • Singapore
          • Thailand
          • Rest of ASEAN Countries
        • Australia
        • South Korea
        • Pakistan
        • Rest of Asia Pacific
    • Middle East & Russia
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
          • Saudi Arabia
          • United Arab Emirates
        • Israel
        • Russia
        • Turkey
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million) and Volume (Thousand Units)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size (US$ Million), Volume (Thousand Units) and Forecast, and Y-o-Y Growth, By Country/Region, 2016–2027)
        • North Africa
          • Algeria
          • Egypt
          • Tunisia
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

Other Related Reports:

Urea Cycle Disorders Treatment Market, by Treatment Type, By Enzyme Deficiency Type, By Route of Administration, By Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2027

Cholangiocarcinoma Market, By Treatment Type, By Distribution Channel, and By Region – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028

Post-traumatic Stress Disorder Treatment Market, by Drug Type, by End-user, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028

Lysosomal Acid Lipase (LAL) Deficiency Treatment Market, by Therapy Type, By Drug Type, By Disease Indication, and By Geography – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2021- 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Sign up and submit a press release

Sponsored
Ark Surgical Performs First Hysterectomies in the USA with its FDA-Cleared LapBox for Manual Morcellation

Ark Surgical Performs First Hysterectomies in the USA with its FDA-Cleared LapBox for Manual Morcellation

PACKAGING COMPLIANCE LABS WELCOMES NEW CFO, BERNADETTE LEGARETTA

PACKAGING COMPLIANCE LABS WELCOMES JENN GOFF, VP SALES, MARKETING, AND INNOVATION

Clarius Debuts its First Dual-Array Wireless Handheld Scanner Enabling Whole-Body Views of Superficial to Deep Anatomy

Clarius Debuts its First Dual-Array Wireless Handheld Scanner Enabling Whole-Body Views of Superficial to Deep Anatomy

National Liver Health Awareness Month Highlights the Urgent Need for Liver Disease Prevention

National Liver Health Awareness Month Highlights the Urgent Need for Liver Disease Prevention

interviews & reviews
A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

A Wearable to Manage Parkinson’s Motor Symptoms: Interview with Lucy Jung, CEO at Charco Neurotech

Eko’s Newest CORE 500 Stethoscope: A Review

Eko’s Newest CORE 500 Stethoscope: A Review

Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

Shear-Thinning Biomaterial for Embolic Applications: Interview with Upma Sharma, President and CEO of Arsenal Medical

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!